June Sherie Almenoff

Insider Reports History

Location
C/O Brainstorm Cell Therapeutics Inc., 1325 Avenue Of Americas 28 Th Floor, New York, NY
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by June Sherie Almenoff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TENAX THERAPEUTICS, INC. Director Stock Option (right to buy) 80K $578K $7.23 Nov 17, 2025 Direct
Avalo Therapeutics, Inc. Director Restricted Stock Units 6.33K $53.6K $8.46 Mar 28, 2025 Direct
Avalo Therapeutics, Inc. Director Common Stock 3.17K $26.8K $8.46 Mar 28, 2025 Direct
TENAX THERAPEUTICS, INC. Director Common Stock 1.99K $15K $7.52 Nov 18, 2025 By Meadowlark Management, LLC
BRAINSTORM CELL THERAPEUTICS INC. Director Common Stock 7.18K $12.7K $1.77 Dec 15, 2021 By Meadowlark Management LLC
BRAINSTORM CELL THERAPEUTICS INC. Director Common Stock 6K $10.6K $1.77 Dec 15, 2021 Direct
Avalo Therapeutics, Inc. Director Common Stock 1K $8.46K $8.46 Mar 28, 2025 By Meadowlark Management, LLC
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 20.1K Jun 17, 2025 Direct
Actinium Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 Mar 31, 2025 Direct

Insider Reports Filed by June Sherie Almenoff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TENX TENAX THERAPEUTICS, INC. Nov 17, 2025 2 $14.9K 4/A Nov 20, 2025 Director
TENX TENAX THERAPEUTICS, INC. Jul 1, 2025 1 $0 4 Jul 3, 2025 Director
AVTX Avalo Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
ATNM Actinium Pharmaceuticals, Inc. Mar 31, 2025 1 $0 4 Apr 2, 2025 Director
AVTX Avalo Therapeutics, Inc. Mar 28, 2025 2 $0 4 Apr 1, 2025 Director
TENX TENAX THERAPEUTICS, INC. Dec 10, 2024 1 $0 4 Dec 12, 2024 Director
AVTX Avalo Therapeutics, Inc. Nov 12, 2024 2 $12.7K 4 Nov 14, 2024 Director
ATNM Actinium Pharmaceuticals, Inc. Nov 1, 2024 1 $0 4 Nov 5, 2024 Director
ATNM Actinium Pharmaceuticals, Inc. Nov 1, 2024 0 $0 3 Nov 5, 2024 Director
AVTX Avalo Therapeutics, Inc. Aug 13, 2024 2 $0 4 Aug 14, 2024 Director
AVTX Avalo Therapeutics, Inc. Dec 20, 2023 1 $0 4 Dec 21, 2023 Director
AVTX Avalo Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
AVTX Avalo Therapeutics, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 Director
AVTX Avalo Therapeutics, Inc. Dec 30, 2022 1 $0 4 Jan 3, 2023 Director
AVTX Avalo Therapeutics, Inc. Sep 30, 2022 1 $0 4 Oct 3, 2022 Director
AVTX Avalo Therapeutics, Inc. Jun 30, 2022 1 $0 4 Jul 1, 2022 Director
AVTX Avalo Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
TENX TENAX THERAPEUTICS, INC. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
AVTX Avalo Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
AVTX Avalo Therapeutics, Inc. Dec 31, 2021 1 $0 4 Jan 4, 2022 Director
BCLI BRAINSTORM CELL THERAPEUTICS INC. Dec 15, 2021 1 $0 4 Dec 17, 2021 Director
BCLI BRAINSTORM CELL THERAPEUTICS INC. Dec 10, 2021 1 $0 4 Dec 10, 2021 Director
AVTX Avalo Therapeutics, Inc. Nov 10, 2021 1 $0 4 Nov 12, 2021 Director
AVTX Avalo Therapeutics, Inc. Nov 10, 2021 0 $0 3 Nov 12, 2021 Director
TENX TENAX THERAPEUTICS, INC. Jun 10, 2021 1 $0 4 Jun 15, 2021 Director
TENX TENAX THERAPEUTICS, INC. Feb 25, 2021 0 $0 3 Apr 12, 2022 Director